Skip to main navigation
Repare Therapeutics
  • Company
    • About Us
    • Leadership
    • Partnering
    • Contact
  • Science
    • Therapeutic Focus
    • Scientific References
  • Pipeline
    • Development Pipeline
    • Polθ Inhibitor
    • RP-1664 PLK4 inhibitor
    • Camonsertib ATR Inhibitor
  • Clinical Trials
    • Clinical Trials Overview
    • Expanded Access Policy
  • Careers
    • Job Opportunities
    • Our Culture
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events & Presentations
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Entity report pursuant to Bill S-211
    • Investor Resources
      • Investor FAQs
      • Investor Email Alerts
      • PFIC Statement
      • Contact IR
Select Page

Press Releases

Press Releases

Mar 03, 2025
Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Jan 09, 2025
Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
Displaying 11 - 12 of 12
Media & IR Contact
Investor Relations & Media Contact

Steve Forte
Contact Us

Helpful Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
Company
  • About Us
  • Leadership
  • Partnering
  • Contact
Science
  • Therapeutic Focus
  • Scientific References
Pipeline
  • Development Pipeline
  • Polθ Inhibitor
  • RP-1664 PLK4 inhibitor
  • Camonsertib ATR Inhibitor
Clinical Trials
  • Clinical Trials Overview
  • Expanded Access Policy
Careers
  • Job Opportunities
  • Our Culture
Investors & Media
  • Corporate Profile
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investor Resources
Repare Therapeutics logo
© 2025 Repare Therapeutics
  • Privacy Policy
  • Terms of Use
  • Cookie Policy